IL-27 mediates the response to IFN-β therapy in multiple sclerosis patients by inhibiting Th17 cells
Cheryl M. Sweeney, Roisin Lonergan, Sharee A. Basdeo, Katie Kinsella, Lara S. Dungan, Sarah C. Higgins, Patrick J. Kelly, Lisa Costelloe, Niall Tubridy, Kingston H.G. Mills, Jean M. FletcherVolume:
25
Year:
2011
Language:
english
Pages:
1182
DOI:
10.1016/j.bbi.2011.03.007
File:
PDF, 601 KB
english, 2011